Pharmaceutical research: set the pace for innovation
Faster from the lab to trials to market: With a set of aligned solutions, you can streamline your pharmaceutical r&d processes.
It takes years to discover a new drug. The preclinical phase which and afterwards the clinical phase which might last for up to 12 years and maybe more it's now time to focus on how to improve your efficiency in your research and development processes. No more laborious tracking of lab tests and results, no more trial and error approaches to recipe and process design, no more time-consuming compilation of data for records and documentation. Utilize the latest digital solutions to enable seamless transition of lab data and recipes to production by integrating R&D with process and product development.
Digital solutions for the pharmaceutical industry at a glance
The LivingLab at the Siemens City in Vienna is the place where visionary ideas are tested under realistic conditions and developed further for your production.
Visit the LivingLab virtually using an interactive graphic and let the experts show you our solutions for the pharmaceutical industry.
Speeding up process and product design
The pharmaceutical industry has always been subject to stringent monitoring and regulations – but in recent years, the pressure from the authorities as well as a shift in market requirements has led to significant changes in the way new drugs are being developed and produced. Both the approval of the new drug and the manufacturing process need to be developed in parallel, and the production equipment must be flexible enough to produce changing amounts of one product or several different products or, ideally, both. Co-evolving drugs and the manufacturing processes also helps shorten the time-to-market, as larger amounts of drugs can be made earlier and the experience gained from the small-scale process can be more easily scaled up to meet commercial production requirements. We help you integrate the various sources of data along the critical stages of pre-clinical testing from clinical trials to industrialization.
Individualized production in Pharma
The future of pharmaceutical care lies in individual drugs that are tailored to the genome of small patient groups or even a single patient.
Via a digital twin, individualized drugs can be produced fast, compliant, affordable and in high-quality.